Pharmaceutical PV DIV - FSB
Ended Indefinite Delivery Contract Awarded
- Contract number
- SPE2DB24D9211
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 77 $212,740 obligated
Award facts
- Opportunity
-
- SPM2DP13R0007 Solicitation number
- Combined order value
- $212,740 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling <1% used
- $499,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, a single-award indefinite delivery contract valued at up to $499,999,999 through December 31, 2025. This contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items including flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, and other branded and generic medications spanning various therapeutic classes. DMS Pharmaceutical Group, a leading pharmaceutical wholesaler, will fulfill the recurring medical supply needs of military health facilities supported by DLA worldwide. This IDV contract complements DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense sites.
The scope of the contract includes delivery of pharmaceutical products such as naltrexone tablets, botulinum toxin injections, contraceptive implants and intrauterine devices, chemotherapy drugs, HIV antiretrovirals, ophthalmic solutions, injectable anesthetics, and other branded and generic medications. DMS Pharmaceutical Group will leverage its expertise in pharmaceutical distribution and cold chain logistics to ensure timely and reliable supply of these critical medical products to support the healthcare needs of U.S. military personnel and their families globally.
Task orders
Show 40 more
Latest 50 of 77 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DB24D9211?
SPE2DB24D9211 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 7, 2024.
How much is contract SPE2DB24D9211 worth?
Orders under SPE2DB24D9211 have obligated $212,740. SPE2DB24D9211's own ceiling is $499,999,999.
How many orders have been placed under contract SPE2DB24D9211?
77 orders have been placed under SPE2DB24D9211, the latest on October 29, 2025.
Who can order from contract SPE2DB24D9211?
SPE2DB24D9211 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DB24D9211 competed?
The extent of competition for SPE2DB24D9211 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV